Recent Articles from GlobeNewswire

MONTVALE, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2025 fiscal fourth quarter and full year ended December 31, 2025. For the quarter, the Company reported net sales of $263.6 million, net earnings of $39.2 million, adjusted EBITDA(a) of $67.9 million, and free cash flow(a) of $51.2 million. For the full year 2025, the Company reported net sales of $1.037 billion, net earnings of $154.8 million, adjusted EBITDA of $274.9 million, and free cash flow of $173.6 million.

LOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- EVgo Inc. (Nasdaq: EVGO), one of the nation’s largest providers of public fast charging infrastructure for electric vehicles (EVs), today announced that it will release its fourth quarter and full year 2025 financial results on Tuesday, March 3. This release will be followed by a webcast hosted by members of the EVgo management team at 8 a.m. ET (5 a.m. PT).

MELBOURNE, Australia and INDIANAPOLIS, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) will participate in the upcoming Oppenheimer 36th Annual Healthcare Life Sciences Conference (virtual) and in the TD Cowen 46th Annual Health Care Conference in Boston, MA (U.S.).

NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments, today announced that it will host a Virtual Investor Day on Friday, March 6, 2026, from 9:00 a.m. to 12:00 p.m. ET. The event will feature presentations and live Q&A sessions with members of the Company’s executive leadership team and several external key opinion leaders.

SILJ delivered 184.02% YTD NAV return in 2025

NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced IEH Corporation (OTCQX: IEHC), a producer of high-performance PCB connectors, has qualified to trade on the OTCQX® Best Market. IEH Corporation upgraded to OTCQX from the OTCID™ Basic Market.

Integrated supply chain leader will drive growth, transformation, and operational excellence

WARREN, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that multiple poster presentations highlighting results from the investigational use of its product candidate Anaphylm™ (dibutepinephrine) sublingual film for the treatment of severe allergic reactions, including anaphylaxis, will be featured at the 2026 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting. The meeting will take place February 27-March 2, 2026, in Philadelphia, PA.

Convex generates record annual results including $711 million in net income

NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced that Chemtrade Logistics Income Fund (TSX: CHE.UN; OTCQX: CGIFF), a diversified operator and producer of industrial chemicals and services, has qualified to trade on the OTCQX® Best Market. Chemtrade Logistics Income Fund upgraded to OTCQX from the Pink Limited™ Market.

SAN JOSE, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Legence Corp. (Nasdaq: LGN) (“Legence” or the “Company”) today announced that it will release results for the fourth quarter and full-year ended December 31, 2025 on Friday, March 27, 2026, prior to the market open.  

SINGAPORE, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (Nasdaq: BTDR) (“Bitdeer”), a world-leading technology company for Bitcoin mining and AI infrastructure, today announced the pricing of its registered direct offering of 5,503,030 of its Class A ordinary shares, par value US$0.0000001 per share (the “Class A ordinary shares”), to certain holders of its 5.25% convertible senior notes due 2029 (the “November 2029 notes”) at a price of US$7.94 per Class A ordinary share in a direct placement registered under the Securities Act of 1933, as amended (the “Securities Act”) (such placement, the “registered direct offering”). The registered direct offering is expected to close on February 26, 2026, subject to customary closing conditions.

Five-year syndicated credit facility at an industry-leading rate of SOFR+500

6 Wins in Last 8 Vegas MLB Exhibition Contests – A Record That Surpasses Even Bill Belichick's Dynasty

SINGAPORE, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (Nasdaq: BTDR) (“Bitdeer”), a world-leading technology company for Bitcoin mining and AI infrastructure, today announced the pricing of US$325.0 million principal amount of 5.00% Convertible Senior Notes due 2032 (the “notes”) in a private placement (the “notes offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The aggregate principal amount of the convertible notes offering was increased from the previously announced offering size of $300.0 million. Bitdeer also granted the initial purchasers of the notes an option to purchase, for settlement within a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional US$50.0 million principal amount of notes. The sale of the notes is expected to close on February 24, 2026, subject to customary closing conditions.

Frontline plc.’s preliminary fourth quarter 2025 results will be released on Friday February 27, 2026, and a webcast and conference call will be held at 3:00 p.m. CET (9:00 a.m. U.S. Eastern Time). The results presentation will be available for download from the Investor Relations section at www.frontlineplc.cy ahead of the conference call.

DEER PARK, Ill., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that members of the Company’s executive leadership team will host one-on-one meetings at the Leerink Partners Global Healthcare Conference on Wednesday, March 11, 2026 in Miami, Florida.

HOUSTON and LONDON, Feb. 20, 2026 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB) today announced its board of directors has declared a quarterly dividend of $0.69 per share, representing a $0.68 per share reduction from the company’s fourth quarter 2025 dividend. The dividend will be paid to shareholders on March 9, 2026, with an ex-dividend and record date of March 2, 2026.

TORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) today released its fourth quarter and full year 2025 financial results and announced 2026 annual production and cost guidance. All amounts are in U.S. dollars, unless otherwise noted.

Three Month Results

BEIJING, Feb. 20, 2026 (GLOBE NEWSWIRE) -- JD.com, Inc. (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and service provider, today announced that it plans to release its unaudited fourth quarter and full year 2025 financial results on Thursday, March 5, 2026, before the U.S. market opens.

Truck and Bus HVAC integration leader Cling has awarded Garrett volume production of its breakthrough oil-free, foil bearing centrifugal compressor, with start of production in 2027

Data from the first in human study on O3R-5671’s potent TNFα inhibition

Transaction marks Apollo’s fifth investment in Aldar and the region’s largest corporate hybrid private placement 

NEEDHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the pricing of an underwritten public offering of 18,348,624 shares of its common stock at a price to the public of $5.45 per share. The gross proceeds to Candel from the offering are expected to be $100 million, before deducting underwriting discounts and commissions and other offering expenses. The offering is expected to close on or about February 23, 2026, subject to customary closing conditions. In addition, Candel has granted the underwriters a 30-day option to purchase up to 2,752,293 additional shares of its common stock at the public offering price, less the underwriting discount.

Quarterly revenue of $748 million; GAAP loss of ($0.20)/share and adjusted EPS of $0.22

NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of ICON Public Limited Company (“ICON” or the “Company”) (NASDAQ:ICLR) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.

NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Paysafe Limited (“Paysafe” or the “Company”) (NYSE:PSFE) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

DOVER, DE, Feb. 19, 2026 (GLOBE NEWSWIRE) -- hey balu, a premier online retailer exclusively dedicated to personalized pet gifts, headquartered in Dover, Delaware, announced the expansion of its U.S.-printed collection of custom-designed pet apparel and home décor. The company confirmed that the expanded lineup is now available nationwide and reinforces its continued focus on made-to-order production and domestic manufacturing standards within the personalized pet sector.

NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) --

MELBOURNE, Australia and INDIANAPOLIS, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the year ended December 31, 2025.

New York, NY, Feb. 19, 2026 (GLOBE NEWSWIRE) -- D. Boral Acquisition I Corp. (the “Company”) today announced that, commencing February 25, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units.

After years of organizing across the political aisle, a broadly supported policy to extend postpartum care to become law

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In NuScale (SMR) To Contact Him Directly To Discuss Their Options

LUXEMBOURG, Feb. 19, 2026 (GLOBE NEWSWIRE) -- On Wednesday, March 4, 2026, Altisource Portfolio Solutions S.A. (“Altisource”) (NASDAQ: ASPS) will report earnings for the fourth quarter 2025. A press release and presentation will be available on Altisource’s website in the Investor Relations section.

NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- If you suffered a loss on your investment in agilon health, inc. (“agilon” or the “Company”) (NYSE:AGL), contact Lauren Molinaro by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased uniQure N.V. (“uniQure” or the “Company”) (NASDAQ:QURE) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

DENVER, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Rank One Computing Corporation d/b/a ROC, (“ROC” or the “Company”), a U.S. leader in multimodal Vision AI, building sovereign biometric, video analytics, and mission intelligence solutions into a unified platform, today announced the pricing of its Initial Public Offering (the “Offering”) of 4,000,000 shares of its common stock at a public offering price of $6.00 per share, which was the high end of the range, for total gross proceeds of $24 million, before deducting underwriting discounts and commissions and other offering expenses. The Company intends to use the net proceeds from the offering (i) to hire key resources that enable growth and support market share capture; (ii) to update and expand our neural-processing infrastructure to accelerate the pace in which we train and deploy Vision AI algorithms; and (iii) for working capital and general corporate purposes. In connection with the Offering, ROC has granted the underwriter a 30-day option to purchase up to an additional 600,000 shares of its common stock to cover over-allotments, if any.

CAMBRIDGE, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, will report fourth quarter and full year 2025 financial results and corporate highlights after the U.S. financial markets close on Thursday, February 26, 2026.

NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Paysafe Limited (NYSE:PSFE) and Oracle Corporation (NYSE:ORCL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Study data show that AdvanceAD-Tx can stratify patients by molecular profile identifying those more likely to achieve near-clear skin (EASI-90), faster time to response and meaningful patient-reported benefits when treated with JAK inhibitor therapy compared to a Th2-targeted therapy

SIMPSONVILLE SC, February 19, 2026, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Dodge Industrial, Inc., a leading provider of innovative industrial solutions, is proud to announce the launch of its new 300-Series mounted ball bearing. Designed to deliver exceptional durability, quality, and reliability, the 300-Series excels in environments where heavy loads and high speeds are common. The bearing features larger ball-shaped rolling elements compared to a traditional 200-series mounted ball bearing, enabling it to handle heavy loads more effectively. Additionally, compared to mounted spherical roller bearings, the ball elements produce less surface contact with the raceway, providing an ideal balance of speed and load performance.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Medpace (MEDP) To Contact Him Directly To Discuss Their Options

LIMERICK, Ireland, Feb. 19, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), the global leader in digital validation and quality process automation, today announced it has signed a Master Services Agreement with a U.S.-headquartered global pharmaceutical packaging and drug-delivery manufacturer.

(Note: All dollar amounts in this news release are expressed in U.S. dollars except as otherwise noted. The financial results are derived from unaudited consolidated financial statements prepared using the recognition and measurement requirements of International Financial Reporting Standards as issued by the International Accounting Standards Board ("IFRS Accounting Standards"). This news release contains certain non-GAAP and other financial measures, including underwriting profit (loss), adjusted operating income (loss), gross premiums written, net premiums written, combined ratio (both discounted and undiscounted), float, book value per basic share, total debt to total capital ratio excluding non-insurance companies and excess (deficiency) of fair value over carrying value, that do not have a prescribed meaning under IFRS Accounting Standards and may not be comparable to similar financial measures presented by other issuers. See "Glossary of non-GAAP and other financial measures" at the end of this news release for further details.)

TORONTO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Centerra Gold Inc. (“Centerra” or the “Company”) (TSX: CG) (NYSE: CGAU) announced today that its Board of Directors has approved a quarterly dividend of C$0.07 per common share – approximately C$14.0 million or US$10.2 million in aggregate. The quarterly dividend is payable on March 26, 2026, to shareholders of record as of the close of business on March 12, 2026. The dividend is an eligible dividend for Canadian income tax purposes.

(All dollar figures are in US dollars, unless otherwise stated)

All figures are in United States dollars unless otherwise stated. This news release contains forward-looking information that is subject to risk factors and assumptions as set out in the “Cautionary Note Regarding Forward-Looking Information” below. 

(In United States dollars, except where noted otherwise)

(All amounts expressed in U.S. dollars unless otherwise noted)

 This news release contains forward-looking information about expected future events that is subject to risks and assumptions set out in the “Cautionary Statement on Forward-Looking Information” below. All figures are in United States dollars. All production figures reflect payable metal quantities and are on a 100% basis, unless otherwise stated. For references denoted with NG, refer to the “Non-GAAP and Other Financial Measures” disclosure at the end of this news release for a description of these measures.

ISELIN, N.J., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Middlesex Water Company (“Middlesex” or the “Company”) (NASDAQ: MSEX) today announced financial results for the fourth quarter and year end 2025.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Klarna (KLAR) To Contact Him Directly To Discuss Their Options

Company opens first two West Virginia travel centers and announces retail transformation with Core-Mark and Pepsi partnerships

San Antonio, TX, Feb. 19, 2026 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (Nasdaq: GROW) will host a webcast on Monday, February 23, at 7:30 a.m. Central time to discuss the company’s results for the second quarter of fiscal year 2026.

SOUTH BEND, Ind., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Strawberry Fields REIT, Inc. (NYSE AMERICAN:STRW) (the “Company”) reported today its operating results for the year ended December 31, 2025.

Phase 1b expansion cohort data evaluating 2000mg of ficerafusp alfa every other week in combination with pembrolizumab in 1L HPV-negative R/M HNSCC patients demonstrate rapid, deep and durable responses with generally well-tolerated safety profile 

SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that Sean P. Bohen, M.D., Ph.D., President and Chief Executive Officer, will present at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026 at 2:30 p.m. ET.

EMERYVILLE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference taking place February 25-26, 2026.

Westwood Salient Enhanced Midstream Income ETF (MDST) reaches $200 million in AUM

St. Petersburg, Fla., Feb. 19, 2026 (GLOBE NEWSWIRE) -- On February 19, 2026, the Raymond James Financial, Inc. (NYSE: RJF) Board of Directors declared a quarterly cash dividend on shares of its common stock of $0.54 per share, payable April 15, 2026 to shareholders of record on April 1, 2026.

HOUSTON, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE: NX) (“Quanex” or the “Company”) today announced plans to release its first quarter 2026 results on Thursday, March 5, 2026, after trading closes on the New York Stock Exchange.

Quarterly revenue of $748 million; GAAP loss of ($0.20)/share and adjusted EPS of $0.22

DHT Holdings, Inc. secures one-year time charter for DHT Taiga

HOUSTON, Feb. 19, 2026 (GLOBE NEWSWIRE) -- KBR (NYSE: KBR) announced today that its Board of Directors has declared a regular quarterly dividend of $0.165 per share on the company’s common stock, par value $0.001 per share, to be paid on April 15, 2026, to stockholders of record on March 13, 2026.

Company to Host Conference Call on Friday, February 20, 2026, at 11:00 a.m. Eastern Standard Time

Increases 2026 capital return objectives to up to $800 million and renews normal course issuer bid

AUSTIN, Texas, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Digital Realty (NYSE: DLR), the largest global provider of cloud- and carrier-neutral data center, colocation, and interconnection solutions, announced today its board of directors has authorized quarterly cash dividends for common and preferred stock for the first quarter of 2026.

Full-year 2025 revenue from continuing operations grew 14% YoY for the second consecutive year

Exceeded Q4 2025 Outlook for Revenue and Adjusted EBITDA, with Strong Adjusted Free Cash Flow

SAN CLEMENTE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended December 31, 2025.

October 2025 acquisition cohort tracking as best-performing October in Company history; acquisitions increased 46% quarter-over-quarter while inventory days in possession reduced 23%

SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months and full year ended December 31, 2025.